UC1MT (Biohaven Pharmaceutical Holding Company/University of Connecticut)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUC1MT (Biohaven Pharmaceutical Holding Company/University of Connecticut)
Drug Alias NameC1MT - Biohaven Pharmaceutical Holding Company/University of ConnecticutAnti-metallothionein antibody - Biohaven Pharmaceutical Holding Company/University of Connecticut
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsMetallothionein inhibitors
TargetsMetallothionein
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A